NUVL Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Nuvalent, Inc.

Nuvalent to Participate in the Cantor Global Healthcare Conference 2025

2 months ago - By: Benzinga - Mentions: AVAV CLS TMO VRT

This Thermo Fisher Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

3 months ago - By: Nuvalent, Inc.

Nuvalent to Present Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 Presidential Symposium

3 months ago - By: Nuvalent, Inc.

Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results

4 months ago - By: Nuvalent, Inc.

Nuvalent Appoints Christy Oliger to Board of Directors

15 hours ago - By: Benzinga - Mentions: IR CDP ENTG BUD ...

Earnings Scheduled For October 30, 2025

16 hours ago - By: Nuvalent, Inc.

Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2025 Financial Results

13 days ago - By: Nuvalent, Inc.

Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025

17 days ago - By: Nuvalent, Inc.

Nuvalent to Present New Preclinical Data for HER2-Selective Inhibitor, NVL-330, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

a month ago - By: Nuvalent, Inc.

Nuvalent to Participate in the UBS 2025 Virtual Oncology Day

2 months ago - By: Nuvalent, Inc.

Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025

3 months ago - By: The Motley Fool

Nuvalent (NUVL) Q2 R&D Up 65%

3 months ago - By: Nuvalent, Inc.

Nuvalent Announces Initiation of ALKAZAR Phase 3 Randomized, Controlled Trial Evaluating Neladalkib for Patients with TKI-naïve ALK-positive NSCLC

4 months ago - By: Yahoo Finance - Mentions: NUVB GS

JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans

4 months ago - By: Yahoo Finance - Mentions: MSFT

Nuvalent price target raised to $140 from $125 at Leerink

4 months ago - By: Yahoo Finance - Mentions: MSFT

Nuvalent price target raised to $130 from $110 at H.C. Wainwright

4 months ago - By: Nuvalent, Inc.

Nuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC

4 months ago - By: Nuvalent, Inc.

Nuvalent Announces Timing of Pivotal Data for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC from ARROS-1 Clinical Trial of Zidesamtinib

6 months ago - By: Nuvalent, Inc.

Nuvalent Outlines Recent Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2025 Financial Results

6 months ago - By: Nuvalent, Inc.

Nuvalent Announces Publication in Molecular Cancer Therapeutics Reinforcing Rational Molecular Design of Zidesamtinib as a Novel ROS1-Selective Inhibitor

6 months ago - By: Yahoo Finance - Mentions: ERJ ACLX BKR META ...

Embraer announces Q1-end backlog of $26.4B

6 months ago - By: Yahoo Finance - Mentions: ADMA ACLX META ERJ ...

ADMA Biologics, Inc. (ADMA): Among Takeover Rumors Hedge Funds Are Buying

6 months ago - By: Yahoo Finance - Mentions: BP ACLX ERJ DHI ...

BP p.l.c. (BP): Among Takeover Rumors Hedge Funds Are Buying

6 months ago - By: Yahoo Finance - Mentions: ALAB ERJ ACLX AXP ...

Nuvalent, Inc. (NUVL): Among Takeover Rumors Hedge Funds Are Buying

6 months ago - By: Yahoo Finance - Mentions: JNPR BPMC BMRN CHWY ...

Juniper Networks, Inc. (JNPR): Among Takeover Rumors Hedge Funds Are Buying

6 months ago - By: Yahoo Finance - Mentions: BPMC KNX BMRN TXRH ...

Blueprint Medicines Corporation (BPMC): Among Takeover Rumors Hedge Funds Are Buying

6 months ago - By: Yahoo Finance - Mentions: X BPMC TXRH KNX ...

United States Steel Corporation (X): Among Takeover Rumors Hedge Funds Are Buying

6 months ago - By: Yahoo Finance - Mentions: FSLR BMRN BPMC TXRH ...

First Solar, Inc. (FSLR): Among Takeover Rumors Hedge Funds Are Buying

6 months ago - By: Yahoo Finance - Mentions: VZ BE AMZN ALAB ...

Astera Labs, Inc. (ALAB): A Bull Case Theory

6 months ago - By: Yahoo Finance - Mentions: BMRN WHR BPMC KNX ...

1 No-Brainer Growth S&P Index Fund to Buy Right Now for Less Than $500

6 months ago - By: Yahoo Finance - Mentions: DHI CMG AAPL

Is Nuvalent, Inc. (NUVL) Among the Best Guru Stocks to Buy According to Wall Street Analysts?

6 months ago - By: Yahoo Finance - Mentions: BAC JPM AXP C ...

Why Bank of America, JPMorgan Chase, and American Express Stocks All Popped Today

6 months ago - By: Nuvalent, Inc.

Nuvalent to Present Trial in Progress Posters for the ALKAZAR Trial of Neladalkib and HEROEX-1 Trial of NVL-330 at the 2025 American Society of Clinical Oncology Annual Meeting

7 months ago - By: Yahoo Finance - Mentions: TSLA

Spanish bakery group Europastry sells 20% stake to CriteriaCaixa

7 months ago - By: Yahoo Finance

Is Nuvalent (NUVL) the Best Debt Free Mid Cap Stock to Buy Now?

7 months ago - By: Nuvalent, Inc.

Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

7 months ago - By: Yahoo Finance - Mentions: F QTWO GM CPRI ...

NUVALENT INC-A (NUVL) Stock News

NUVL Latest News, Press Relases and Analysis

Nuvalent to Participate in the Cantor Global Healthcare Conference 2025

This Thermo Fisher Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Nuvalent to Present Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 Presidential Symposium

Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results

Nuvalent Appoints Christy Oliger to Board of Directors

Earnings Scheduled For October 30, 2025

Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2025 Financial Results

Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025

Nuvalent to Present New Preclinical Data for HER2-Selective Inhibitor, NVL-330, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Nuvalent to Participate in the UBS 2025 Virtual Oncology Day

Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025

Nuvalent (NUVL) Q2 R&D Up 65%

Nuvalent Announces Initiation of ALKAZAR Phase 3 Randomized, Controlled Trial Evaluating Neladalkib for Patients with TKI-naïve ALK-positive NSCLC

JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans

Nuvalent price target raised to $140 from $125 at Leerink

Nuvalent price target raised to $130 from $110 at H.C. Wainwright

Nuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC

Nuvalent Announces Timing of Pivotal Data for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC from ARROS-1 Clinical Trial of Zidesamtinib

Nuvalent Outlines Recent Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2025 Financial Results

Nuvalent Announces Publication in Molecular Cancer Therapeutics Reinforcing Rational Molecular Design of Zidesamtinib as a Novel ROS1-Selective Inhibitor

Embraer announces Q1-end backlog of $26.4B

ADMA Biologics, Inc. (ADMA): Among Takeover Rumors Hedge Funds Are Buying

BP p.l.c. (BP): Among Takeover Rumors Hedge Funds Are Buying

Nuvalent, Inc. (NUVL): Among Takeover Rumors Hedge Funds Are Buying

Juniper Networks, Inc. (JNPR): Among Takeover Rumors Hedge Funds Are Buying

Blueprint Medicines Corporation (BPMC): Among Takeover Rumors Hedge Funds Are Buying

United States Steel Corporation (X): Among Takeover Rumors Hedge Funds Are Buying

First Solar, Inc. (FSLR): Among Takeover Rumors Hedge Funds Are Buying

Astera Labs, Inc. (ALAB): A Bull Case Theory

1 No-Brainer Growth S&P Index Fund to Buy Right Now for Less Than $500

Is Nuvalent, Inc. (NUVL) Among the Best Guru Stocks to Buy According to Wall Street Analysts?

Why Bank of America, JPMorgan Chase, and American Express Stocks All Popped Today

Nuvalent to Present Trial in Progress Posters for the ALKAZAR Trial of Neladalkib and HEROEX-1 Trial of NVL-330 at the 2025 American Society of Clinical Oncology Annual Meeting

Spanish bakery group Europastry sells 20% stake to CriteriaCaixa

Is Nuvalent (NUVL) the Best Debt Free Mid Cap Stock to Buy Now?

Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Ford asks investors to vote down supply chain emissions proposal